The estimated Net Worth of Timothy Nicholas Brady is at least $335 dollars as of 12 August 2020. Timothy Brady owns over 1,741 units of Endologix stock worth over $196 and over the last 4 years Timothy sold ELGX stock worth over $139.
Timothy has made over 1 trades of the Endologix stock since 2020, according to the Form 4 filled with the SEC. Most recently Timothy sold 1,741 units of ELGX stock worth $139 on 12 August 2020.
The largest trade Timothy's ever made was selling 1,741 units of Endologix stock on 12 August 2020 worth over $139. On average, Timothy trades about 1,741 units every 0 days since 2020. As of 12 August 2020 Timothy still owns at least 891 units of Endologix stock.
You can see the complete history of Timothy Brady stock trades at the bottom of the page.
Timothy's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott oraz Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: